Ping An Biomedical Gets Nasdaq Extension for $1 Bid Price Compliance

Key Highlights

• Ping An Biomedical received a Nasdaq notification on November 24, 2025, for non-compliance with the $1 minimum bid price rule.
• The non-compliance was based on the closing bid price from October 10, 2025, to November 20, 2025.
• Nasdaq granted an additional 180-calendar-day period, until November 23, 2026, to regain compliance.
• The extension is contingent on meeting other listing requirements and the company's intent to cure the deficiency.
• The company plans to cure the deficiency, potentially through a reverse stock split.
• Compliance requires the closing bid price to be at least $1 per share for a minimum of 10 consecutive business days.